{"id":628,"date":"2026-11-04T08:25:02","date_gmt":"2026-11-04T08:25:02","guid":{"rendered":"https:\/\/dashboard.bluntlinenetwork.com\/en\/?p=628"},"modified":"2026-11-04T08:25:02","modified_gmt":"2026-11-04T08:25:02","slug":"scientists-develop-experimental-device-to-control-blood-sugar-without-insulin-offering-new-hope-for-diabetes-treatment","status":"publish","type":"post","link":"https:\/\/dashboard.bluntlinenetwork.com\/en\/2026\/11\/04\/628","title":{"rendered":"Scientists Develop Experimental Device to Control Blood Sugar Without Insulin, Offering New Hope for Diabetes Treatment"},"content":{"rendered":"\n

Scientists in Switzerland have developed an experimental implantable device that uses electricity to reduce blood sugar levels without directly relying on insulin. Researchers at ETH Zurich say the technology converts excess glucose into gluconate, which can be eliminated through the kidneys. Early experiments in mice have shown promising results in automatically controlling blood sugar and increasing the body’s use of stored fat. However, the device remains in the experimental stage and has not yet been proven safe or effective in humans.<\/strong><\/p>\n\n\n\n

ZURICH, SWITZERLAND:<\/strong> A new scientific development could open the door to alternative treatments for diabetes after researchers in Switzerland developed an experimental device designed to lower blood glucose levels using electricity.<\/p>\n\n\n\n

According to a November 4, 2026, report by Samaa TV, scientists at ETH Zurich have created an implantable system that uses an electrical process to convert excess glucose in the blood into another substance.<\/p>\n\n\n\n

The technology aims to reduce elevated blood sugar through a mechanism different from the traditional action of insulin.<\/p>\n\n\n\n

Researchers have reportedly tested the system in mice, where it demonstrated the ability to regulate glucose levels automatically.<\/p>\n\n\n\n

The experiments also suggested that the device could increase the body’s use of stored fat, raising the possibility of future applications in both diabetes and obesity treatment.<\/p>\n\n\n\n

However, scientists have emphasized that further research and clinical trials are required before the technology can be considered for human use.<\/p>\n\n\n\n

How Does the New Blood Sugar Control Device Work?<\/h2>\n\n\n\n

The experimental device is designed to reduce excess glucose through an electrically driven chemical process.<\/p>\n\n\n\n

Glucose is a type of sugar that circulates in the blood and provides energy to cells throughout the body.<\/p>\n\n\n\n

Under normal conditions, insulin helps regulate blood glucose by allowing cells to absorb and use it.<\/p>\n\n\n\n

In people with diabetes, the body either produces insufficient insulin or cannot use insulin effectively.<\/p>\n\n\n\n

As a result, glucose may accumulate in the bloodstream, leading to elevated blood sugar levels.<\/p>\n\n\n\n

The experimental device developed by ETH Zurich researchers takes a different approach.<\/p>\n\n\n\n

According to the report, it uses electricity to convert excess glucose into a compound called gluconate.<\/p>\n\n\n\n

The resulting substance can then be removed from the body through the kidneys and urine.<\/p>\n\n\n\n

By converting some of the circulating glucose, the device may help reduce blood sugar levels without depending directly on insulin to produce that particular effect.<\/p>\n\n\n\n

However, researchers must still determine how safely and effectively this process can operate over extended periods.<\/p>\n\n\n\n

What Is Gluconate and Why Is It Important?<\/h2>\n\n\n\n

Gluconate is a compound that can be produced through the chemical oxidation of glucose.<\/p>\n\n\n\n

The experimental technology uses an electrical process to support this conversion.<\/p>\n\n\n\n

The idea is that converting excess glucose into another compound could reduce the amount of glucose circulating in the bloodstream.<\/p>\n\n\n\n

According to the research described in the report, the resulting gluconate can be eliminated through the kidneys.<\/p>\n\n\n\n

This approach is scientifically interesting because it explores an alternative route for controlling elevated blood sugar.<\/p>\n\n\n\n

However, glucose is essential for the body’s normal functioning.<\/p>\n\n\n\n

The brain, muscles and other tissues depend on an adequate energy supply.<\/p>\n\n\n\n

Therefore, any technology designed to remove glucose from the bloodstream must be carefully controlled to avoid lowering blood sugar excessively.<\/p>\n\n\n\n

Further studies will be needed to examine the consequences of repeated glucose conversion and the long-term effects of eliminating gluconate through the kidneys.<\/p>\n\n\n\n

Wireless Technology Helps the Device Control Glucose Automatically<\/h2>\n\n\n\n

One of the notable features of the new system is its use of wireless technology.<\/p>\n\n\n\n

According to the report, researchers connected the experimental device to a continuous glucose monitoring system.<\/p>\n\n\n\n

Continuous glucose monitoring, commonly known as CGM, allows glucose levels to be tracked regularly throughout the day and night.<\/p>\n\n\n\n

These systems are already used by many people with diabetes to understand changes in glucose levels.<\/p>\n\n\n\n

In the experimental setup, glucose monitoring information was linked to the device’s operation.<\/p>\n\n\n\n

The goal was to create a system capable of responding automatically to changes in blood sugar.<\/p>\n\n\n\n

During experiments involving mice, researchers reportedly observed automatic glucose regulation.<\/p>\n\n\n\n

This suggests the possibility of developing a system that adjusts its activity according to glucose readings.<\/p>\n\n\n\n

However, the accuracy, reliability and safety of such automatic control would need extensive testing before use in humans.<\/p>\n\n\n\n

Experiments in Mice Show Promising Results<\/h2>\n\n\n\n

Researchers initially tested the device in mice rather than humans.<\/p>\n\n\n\n

According to the reported findings, the system successfully demonstrated its ability to lower blood glucose levels.<\/p>\n\n\n\n

When connected to continuous glucose monitoring, the device also showed promising results in regulating blood sugar automatically.<\/p>\n\n\n\n

Another observation involved changes in the use of stored body fat.<\/p>\n\n\n\n

The experiments suggested that the device could encourage the body to use more stored fat for energy.<\/p>\n\n\n\n

These results are significant because diabetes and obesity can be closely connected, particularly in people with type 2 diabetes.<\/p>\n\n\n\n

However, results obtained in mice do not necessarily predict the same outcomes in humans.<\/p>\n\n\n\n

Human metabolism, body size, organ function and responses to implanted medical devices can differ considerably from those of laboratory animals.<\/p>\n\n\n\n

The technology therefore requires additional research before any conclusions can be drawn about its clinical effectiveness.<\/p>\n\n\n\n

Could the Device Also Help Treat Obesity?<\/h2>\n\n\n\n

The researchers’ findings have raised interest in whether the device might eventually have applications beyond blood sugar control.<\/p>\n\n\n\n

According to the report, experiments in mice showed increased use of stored body fat.<\/p>\n\n\n\n

The human body normally obtains energy from different sources, including glucose and fat.<\/p>\n\n\n\n

Changes in how glucose is processed may influence how the body uses these energy sources.<\/p>\n\n\n\n

If future research confirms that the device can safely affect energy metabolism, it could potentially become relevant to obesity treatment.<\/p>\n\n\n\n

However, an increase in fat utilization does not automatically prove meaningful or lasting weight loss.<\/p>\n\n\n\n

Researchers would need to measure changes in body weight, body composition, metabolic health and long-term safety.<\/p>\n\n\n\n

At present, there is insufficient evidence to claim that the device is an effective treatment for obesity in humans.<\/p>\n\n\n\n

Can This Technology Replace Insulin Injections?<\/h2>\n\n\n\n

The possibility of controlling blood sugar without directly using insulin is one of the most interesting aspects of the research.<\/p>\n\n\n\n

However, the device should not be described as a proven replacement for insulin treatment.<\/p>\n\n\n\n

Insulin performs several essential functions in the human body beyond simply reducing blood glucose.<\/p>\n\n\n\n

It helps regulate how cells use and store nutrients and plays an important role in normal metabolism.<\/p>\n\n\n\n

People with type 1 diabetes generally require insulin because their bodies produce little or none of the hormone.<\/p>\n\n\n\n

Removing excess glucose from the bloodstream does not necessarily replace all of insulin’s biological functions.<\/p>\n\n\n\n

For this reason, researchers must determine whether the technology could serve as a supplementary treatment, an alternative for selected patients or another form of glucose management.<\/p>\n\n\n\n

There is currently no evidence from human clinical trials establishing that the device can replace prescribed insulin therapy.<\/p>\n\n\n\n

Understanding Diabetes and Its Effects on the Body<\/h2>\n\n\n\n

Diabetes is a long-term medical condition characterized by elevated blood glucose levels.<\/p>\n\n\n\n

The condition develops when the body cannot produce enough insulin or cannot use insulin effectively.<\/p>\n\n\n\n

The two main forms are type 1 and type 2 diabetes.<\/p>\n\n\n\n

In type 1 diabetes, the body’s immune system damages the cells responsible for producing insulin.<\/p>\n\n\n\n

People with this condition require insulin treatment to survive.<\/p>\n\n\n\n

Type 2 diabetes is commonly associated with insulin resistance, a condition in which cells respond less effectively to insulin.<\/p>\n\n\n\n

Over time, insulin production may also decline.<\/p>\n\n\n\n

Persistently high blood sugar can damage blood vessels and nerves, increasing the risk of complications involving the heart, kidneys, eyes and other organs.<\/p>\n\n\n\n

Managing glucose levels is therefore an important part of diabetes care.<\/p>\n\n\n\n

The Connection Between Diabetes and Obesity<\/h2>\n\n\n\n

Obesity is an important risk factor for type 2 diabetes, although not everyone with obesity develops the condition.<\/p>\n\n\n\n

Excess body fat, particularly around the abdomen, can contribute to insulin resistance.<\/p>\n\n\n\n

When the body becomes less responsive to insulin, it may need to produce more of the hormone to maintain normal blood glucose levels.<\/p>\n\n\n\n

Over time, this process can contribute to the development of type 2 diabetes.<\/p>\n\n\n\n

Managing body weight can help improve metabolic health for some people with the condition.<\/p>\n\n\n\n

Treatment commonly involves appropriate nutrition, physical activity and medication when required.<\/p>\n\n\n\n

The experimental Swiss device is attracting attention because it may influence both glucose regulation and the use of stored fat.<\/p>\n\n\n\n

However, the relationship between these effects and long-term health outcomes has not yet been established in humans.<\/p>\n\n\n\n

What Are the Potential Risks of an Implantable Glucose-Control Device?<\/h2>\n\n\n\n

Any medical device intended for implantation inside the body must undergo extensive safety testing.<\/p>\n\n\n\n

Researchers need to determine whether the materials used in the device are compatible with human tissues.<\/p>\n\n\n\n

They must also examine possible complications such as infection, inflammation, device malfunction and the effects of long-term implantation.<\/p>\n\n\n\n

Because this technology uses an electrical process, its effects on surrounding tissues and body chemistry must be carefully assessed.<\/p>\n\n\n\n

Another important concern is preventing blood sugar from falling below a safe level.<\/p>\n\n\n\n

A system that removes too much glucose could potentially cause dangerous hypoglycemia.<\/p>\n\n\n\n

The effects of repeated gluconate production and elimination through the kidneys also require further investigation.<\/p>\n\n\n\n

The supplied report does not provide complete safety data addressing these questions.<\/p>\n\n\n\n

They remain important areas for future research.<\/p>\n\n\n\n

When Will the Device Be Available for Human Use?<\/h2>\n\n\n\n

The technology is still in the experimental stage.<\/p>\n\n\n\n

According to the report, the findings described so far come from experiments involving mice.<\/p>\n\n\n\n

Before the device can become an approved treatment, researchers would need to complete additional laboratory studies and obtain the necessary approvals for human clinical trials.<\/p>\n\n\n\n

Clinical trials assess whether a new medical technology is safe, whether it provides meaningful benefits and whether those benefits outweigh possible risks.<\/p>\n\n\n\n

Researchers would also need to determine which patients might benefit from the device and how it compares with existing treatments.<\/p>\n\n\n\n

The report did not provide a confirmed date for human trials.<\/p>\n\n\n\n

It also did not announce a commercial launch date or expected price.<\/p>\n\n\n\n

Therefore, it would be premature to suggest that the technology will soon be available to patients.<\/p>\n\n\n\n

Why This Research Could Be Important for Future Diabetes Treatment<\/h2>\n\n\n\n

Diabetes treatment has advanced considerably through the development of insulin formulations, glucose monitoring systems and automated insulin delivery technology.<\/p>\n\n\n\n

However, researchers continue to investigate additional methods of controlling blood sugar.<\/p>\n\n\n\n

The ETH Zurich device represents a different approach because it aims to reduce excess glucose through an electrically driven conversion process.<\/p>\n\n\n\n

If the technology eventually proves safe and effective in humans, it could potentially expand the range of treatment options available to selected patients.<\/p>\n\n\n\n

Its integration with continuous glucose monitoring is another promising feature because automatic glucose regulation could reduce the need for some manual adjustments.<\/p>\n\n\n\n

Nevertheless, important questions remain about safety, reliability, long-term effectiveness and patient suitability.<\/p>\n\n\n\n

The technology should currently be viewed as an early scientific development rather than an established medical breakthrough ready for routine treatment.<\/p>\n\n\n\n

Patients Should Not Stop Taking Insulin or Diabetes Medication<\/h2>\n\n\n\n

Although the research offers hope for future treatments, people with diabetes should continue following their prescribed medical plans.<\/p>\n\n\n\n

The experimental device has not been approved for human use and has not been demonstrated to replace existing diabetes medications.<\/p>\n\n\n\n

Stopping insulin or other prescribed treatment without medical supervision can cause serious complications.<\/p>\n\n\n\n

This is especially dangerous for people with type 1 diabetes, who depend on insulin.<\/p>\n\n\n\n

Patients should continue monitoring their blood sugar as recommended and consult their healthcare professionals before making changes to treatment.<\/p>\n\n\n\n

New scientific findings can be encouraging, but they do not automatically change established medical recommendations.<\/p>\n\n\n\n

Swiss Scientists Open a New Direction in Diabetes Research<\/h2>\n\n\n\n

Researchers at ETH Zurich have developed an experimental implantable device that uses electricity to convert excess blood glucose into gluconate.<\/p>\n\n\n\n

According to the November 4, 2026, media report, the device can work with a wireless glucose monitoring system to regulate blood sugar automatically.<\/p>\n\n\n\n

Experiments in mice have produced promising results, including reduced glucose levels and increased use of stored body fat.<\/p>\n\n\n\n

These findings suggest that the technology may eventually contribute to research into treatments for diabetes and obesity.<\/p>\n\n\n\n

However, the device remains at an early stage of development.<\/p>\n\n\n\n

Its safety, effectiveness and long-term impact must be established through further studies and human clinical trials.<\/p>\n\n\n\n

For now, the research represents a promising new direction in medical technology, not a confirmed cure for diabetes or a proven replacement for insulin.<\/p>\n","protected":false},"excerpt":{"rendered":"

Scientists in Switzerland have developed an experimental implantable device that uses electricity to reduce blood sugar levels without directly relying […]<\/p>\n","protected":false},"author":1,"featured_media":629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[22,25],"tags":[401,122,96,404,402,400,403,83],"class_list":["post-628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-important-news","tag-blood-sugar-control","tag-bluntline-network","tag-current-affairs","tag-diabetes-research","tag-diabetes-technology","tag-eth-zurich","tag-insulin-free-device","tag-latest-news"],"_links":{"self":[{"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/posts\/628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/comments?post=628"}],"version-history":[{"count":1,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/posts\/628\/revisions"}],"predecessor-version":[{"id":630,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/posts\/628\/revisions\/630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/media\/629"}],"wp:attachment":[{"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/media?parent=628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/categories?post=628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dashboard.bluntlinenetwork.com\/en\/wp-json\/wp\/v2\/tags?post=628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}